Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Allergic Skin Diseases
•
Drug Allergy
Do you utilize any desensitization protocols for delayed hypersensitivity reactions?
Related Questions
Do you recommend desensitization to biologics since this has to occur repeatedly?
Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?
What type of DES should you opt for if a patient has or is concerned about possible nickel allergy?
Are you using any AI models to de-label penicillin allergy?
Is immunoglobulin replacement an option for CRS in a patient with normal immune function?
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
Would you consider rechallenging immunotherapy if the first dose was accompanied with an acute infusion reaction with low back pain, shortness of breath and chest pain which resolved with monitoring, and subsequent cardiac workup being negative?
How would you approach an asymptomatic older female patient with eosinophilia to 17,000, present for years, and normal eosinophilia workup including marrow and negative FLIP1?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
